Thermo Fisher Scientific
TMO
682.16
+2.78
+0.41%
Thermo Fisher Scientific
US · TMO
#80 by market cap
Listed 1970
682.16
+2.78
+0.41%
Live - 5344 symbols - heartbeat 376s ago
· 2026-10-20 10:50
Analyst consensus 16 analysts
Buy
Avg price target 673.07 -1.3%
Price target rangecurrent 682.16
Low580.00
Avg673.07
High750.00
Buy 88%
Hold 13%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-09 | BofA Securities | -- | Buy | 745.00 |
| 2026-10-07 | Barclays | -- | Buy | 750.00 |
| 2026-09-25 | Deutsche Bank | -- | Buy | 720.00 |
| 2026-09-15 | Stifel | -- | Buy | -- |
| 2026-09-08 | UBS | -- | Buy | 730.00 |
| 2026-09-03 | CLSA | -- | Buy | 748.00 |
| 2026-08-05 | Stifel | -- | Buy | 650.00 |
| 2026-07-28 | J.P. Morgan | -- | Buy | 690.00 |
| 2026-07-27 | Piper Sandler | -- | Hold | 600.00 |
| 2026-07-27 | DZ BANK AG | -- | Buy | 630.00 |
| 2026-07-27 | CMBI | -- | Buy | 660.00 |
| 2026-07-24 | William Blair | -- | Buy | -- |
| 2026-07-24 | Morgan Stanley | -- | Buy | 650.00 |
| 2026-07-24 | Stifel | -- | Buy | 600.00 |
| 2026-07-24 | Barclays | -- | Buy | 650.00 |
| 2026-07-23 | TD Cowen | -- | Buy | 675.00 |
| 2026-07-23 | Wells Fargo | -- | Buy | 615.00 |
| 2026-07-23 | BofA Securities | -- | Buy | 650.00 |
| 2026-07-23 | Jefferies | -- | Buy | 630.00 |
| 2026-07-23 | RBC Capital | -- | Hold | 580.00 |
| 2026-07-22 | Wells Fargo | -- | Buy | 615.00 |
| 2026-07-14 | Wells Fargo | -- | Buy | 615.00 |
| 2026-07-10 | Morgan Stanley | -- | Buy | 620.00 |
| 2026-07-09 | Deutsche Bank | -- | Buy | 630.00 |
| 2026-07-06 | Evercore | -- | Buy | 570.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
3 2
■ Upgrades■ Downgrades
- 3 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: UBS moved from Hold to Buy on 2026-09-08.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-08 | UBS | Hold → Buy | 730.00 |
| 2026-06-25 | Bernstein | Buy → Hold | 520.00 |
| 2026-06-03 | HSBC | Buy → Hold | 540.00 |
| 2025-12-11 | Citi | Hold → Buy | 660.00 |
| 2025-12-07 | KeyBanc | Hold → Buy | 750.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-23 | -- | ±5.65% | +8.71% (beat) |
| 2026/Q1 | 2026-04-23 | -- | ±4.61% | -9.20% (beat) |
| 2025/Q4 | 2026-01-29 | -- | ±4.25% | -2.61% (in line) |
| 2025/Q3 | 2025-10-22 | -- | ±4.38% | +1.65% (in line) |
| 2025/Q2 | 2025-07-23 | -- | ±5.20% | +9.14% (beat) |
| 2025/Q1 | 2025-04-23 | -- | ±5.55% | -0.71% (in line) |
| 2024/Q4 | 2025-01-30 | -- | ±4.72% | +6.78% (beat) |
| 2024/Q3 | 2024-10-23 | -- | ±4.28% | -1.69% (in line) |
| 2024/Q2 | 2024-07-24 | -- | ±4.02% | +4.07% (beat) |
| 2024/Q1 | 2024-04-24 | -- | ±4.41% | +0.49% (in line) |
| 2023/Q4 | 2024-01-31 | -- | ±3.78% | -4.96% (beat) |
| 2023/Q3 | 2023-10-25 | -- | ±4.26% | -5.47% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-20 10:50:14 · For reference only, not investment advice and not tailored to your situation.
Thermo Fisher Scientific discussion 0 comments